Literature DB >> 10938446

Reduced plasma leptin concentrations in bulimia nervosa.

T D Brewerton1, M D Lesem, A Kennedy, W T Garvey.   

Abstract

Leptin is a protein produced by the ob-ob gene which inhibits food intake. Plasma levels have previously been reported to be altered in obesity and anorexia nervosa (AN) but not bulimia nervosa (BN). We measured fasting plasma leptin levels by radioimmunoassay in 53 subjects carefully studied at NIMH, including 37 women meeting DSM-III-R criteria for BN [10 with concurrent AN (body mass index (BMI)=14.1+/-1.4), 27 without AN (BMI=20.4+/-1.6)] and 16 normal control women (NCs) (BMI=21.1+/-2.0). Patients were medication-free and abstinent from bingeing and purging for three to four weeks prior to study. Plasma leptin levels were significantly correlated to BMI (r=0.41, P<0.002), weight (kg, r=0.43, P<0.001), and percent average body weight (%ABW, r=0.45, P<0.001) in the total group. Plasma leptin levels were lower in the BN subjects (3.4+/-2.5 ng/ml) compared to the NCs (6.1+/-2.6 ng/ml, P<0.001, ANCOVA) even after controlling for BMI and weight. There was no significant difference between BN subjects with AN (n=10, 2.6+/-2.6 ng/ml) and those without AN (n=27, 3.8+/-2.4 ng/ml), despite lower BMI in BN with AN. Furthermore, leptin levels were decreased in BN without AN compared with healthy controls, even though BMI was comparable in these two subgroups. Plasma leptin concentrations were negatively correlated with baseline plasma cortisol levels (n=49, r=-0.49, P<0.001) and positively correlated with prolactin responses following L-tryptophan (n=49, r=0.37, P<0.009) and m-chlorophenylpiperazine (n=52, r=0.24, P<0.09). This is the first known report of decreased plasma leptin levels in BN. The decrement in leptin concentration is not related to BMI, body weight, or the presence or absence of BN. HPA axis activation as well as serotonin dysregulation may be related to decreased leptin levels, which may in turn contribute to disinhibited eating in BN. Although current leptin levels were not correlated with self-reported previous binge frequency, the role of leptin in the pathophysiology of BN deserves further study.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10938446     DOI: 10.1016/s0306-4530(00)00016-0

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  8 in total

1.  Correlation between psychometric and biological parameters in anorexic and bulimic patients during and after an intensive day hospital treatment.

Authors:  F Manara; A Manara; P Todisco
Journal:  Eat Weight Disord       Date:  2005-12       Impact factor: 4.652

Review 2.  Examining weight suppression as a transdiagnostic factor influencing illness trajectory in bulimic eating disorders.

Authors:  Pamela K Keel; Lindsay P Bodell; K Jean Forney; Jonathan Appelbaum; Diana Williams
Journal:  Physiol Behav       Date:  2019-05-30

Review 3.  Aetiopathogenesis and pathophysiology of bulimia nervosa: biological bases and implications for treatment.

Authors:  F Brambilla
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

4.  Weight suppression in bulimia nervosa: Associations with biology and behavior.

Authors:  Lindsay P Bodell; Pamela K Keel
Journal:  J Abnorm Psychol       Date:  2015-07-20

5.  Increased plasma asprosin levels are associated with overeating and loss of control in drug-free bulimia nervosa.

Authors:  Yanran Hu; Qing Kang; Chen Chen; Lei Guo; Jue Chen
Journal:  Eat Weight Disord       Date:  2022-06-29       Impact factor: 3.008

6.  Psychobiology of purging disorder: reduction in circulating leptin levels in purging disorder in comparison with controls.

Authors:  David C Jimerson; Barbara E Wolfe; Devon P Carroll; Pamela K Keel
Journal:  Int J Eat Disord       Date:  2010-11-01       Impact factor: 4.861

7.  Risk factors for eating disorders: an umbrella review of published meta-analyses.

Authors:  Marco Solmi; Joaquim Radua; Brendon Stubbs; Valdo Ricca; Davide Moretti; Daniele Busatta; Andre F Carvalho; Elena Dragioti; Angela Favaro; Alessio Maria Monteleone; Jae Il Shin; Paolo Fusar-Poli; Giovanni Castellini
Journal:  Braz J Psychiatry       Date:  2020-09-28       Impact factor: 2.697

Review 8.  The role of "mixed" orexigenic and anorexigenic signals and autoantibodies reacting with appetite-regulating neuropeptides and peptides of the adipose tissue-gut-brain axis: relevance to food intake and nutritional status in patients with anorexia nervosa and bulimia nervosa.

Authors:  Kvido Smitka; Hana Papezova; Karel Vondra; Martin Hill; Vojtech Hainer; Jara Nedvidkova
Journal:  Int J Endocrinol       Date:  2013-09-09       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.